Lior Nesher

2.7k citations

75 papers · 1.5k indexed · 1 hit paper · h-index 18

Impact in

Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Applied Microbiology and Biotechnology top 5%

Papers in

Applied Microbiology and Biotechnology 7
- Antibiotic Use and Resistance 7
Molecular Medicine 12
- Antibiotic Resistance in Bacteria 12

Co-authors: Kenneth V. I. Rolston Roy F. Chemaly Ella Ariza‐Heredia K. V. I. Rolston Carmi Bartal Dimpy P. Shah Arthur Shiyovich Jeffrey Tarrand
Journals: Infectious Diseases and Therapy (5 papers)Infection (4 papers)Infection Control and Hospital Epidemiology (4 papers)Journal of Clinical Medicine (3 papers)The Journal of Antibiotics (2 papers)
Partner nations: Israel United States France

In The Last Decade

Lior Nesher

72 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel 2021 · 199 citations

Peers

Countries citing papers authored by Lior Nesher

Since Specialization

Citations

This map shows the geographic impact of Lior Nesher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lior Nesher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lior Nesher more than expected).

Fields of papers citing papers by Lior Nesher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lior Nesher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lior Nesher. The network helps show where Lior Nesher may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lior Nesher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lior Nesher Line = papers co-authored together Lior Nesher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Invasive Mould Infections Following Combat‐Related Injuries—A Retrospective Cohort Study Mycoses ·V. P. Torchigin, Ana Laura dos Reis, 石韧, Lior Nesher, Paul Hamelius, Zhun Zhong, Tal Brosh‐Nissimov, Sharon Amit, Rufus Adebayo Ajisafe, David R. Tribble, Ronen Ben‐Ami, Dafna Yahav	2025	2
2	The Utility of Blood Cultures in Non-Febrile Patients and Patients with Antibiotics Therapy in Internal Medicine Departments Journal of Clinical Medicine ·장금준, 安田克典, Lior Nesher, Tali Shafat, Victor Novack	2025	0
3	Adult Respiratory Syncytial Virus Infection: Defining Incidence, Risk Factors for Hospitalization, and Poor Outcomes, a Regional Cohort Study, 2016–2022 Pathogens ·Tal Brosh‐Nissimov, Shirasu Tetsuhisa, J Ros-Jellici, Piyush Yadav, Wei-Ren Pan, Cristina Ghadban, Brenda Johana Salamanca Ruiz, Lior Nesher	2024	2
4	Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study Infection ·T. Hamolka, Paul Hamelius, I Zahavi, Nathan Hasson, J.E. Aguayo C., Glendy Lazo Vásquez, Shikhil Puzhakkal, Elad Goldberg, 怜子小早川, Sarah Mariam Gebretsadik, Chen-tao, Sharon Amit, Lior Nesher, Jihad Bishara, Wenjun Zhai, Dafna Yahav, Ili Margalit	2024	0
5	Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020–2022 Scientific Reports ·Orna Schwartz, Jiao Hu, Karla C. Álvarez-Uribe, M. Marguet Guillen, J Torres, ‪Yasmin Maor‬‏, Lior Nesher, Orli Sagi, Avi Peretz	2024	2
6	In vitroactivity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer JAC-Antimicrobial Resistance ·Kenneth V. I. Rolston, Eric Fredricksen, Lior Nesher, Samuel A. Shelburne, Randall A. Prince, Issam Raad	2023	9
7	Detection of extended-spectrum β-lactamase-producing bacteria isolated directly from urine by infrared spectroscopy and machine learning Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy ·Shishir K Chandan, Ch. D. V. Paradesi Rao, Nozima Tursunova Ilhomovna, Lior Nesher, Itshak Lapidot, Ahmad Salman, Mahmoud Huleihel	2023	4
8	The Risk of Rectal Temperature Measurement in Neutropenia Rambam Maimonides Medical Journal ·V R Anand, FluGuo-bao, Lior Nesher, Leonid Barski, Elli Rosenberg, Iftach Sagy	2023	1
9	Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility European Journal of Clinical Microbiology & Infectious Diseases ·Liat Shargian, Mical Paul, Zhao Li-hon, Aret Karademır, Lior Nesher, Pia Raanani, Chen-tao, Oryan Henig, Dafna Yahav	2022	1
10	The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends Data Journal of Medical Internet Research ·Jeong-Hye Kim, Elad Yom‐Tov, Lior Nesher	2022	3
11	Piperacillin–tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen) BMJ Open ·Roni Bitterman, Fidi Koppel, Cristina Mussini, Yuval Geffen, Michal Chowers, Galia Rahav, Lior Nesher, Ronen Ben‐Ami, ‪Adi Turjeman‬‏, 손지한, Matthew P. Cheng, Todd C. Lee, Leonard Leibovici, Dafna Yahav, Mical Paul	2021	17
12	An outbreak of coronavirus disease 2019 (COVID-19) in hematology staff via airborne transmission Infection Control and Hospital Epidemiology ·Lisa Saidel‐Odes, Lior Nesher, Ronit Nativ, Abraham Borer	2021	2
13	1589P Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options Annals of Oncology ·Piero M Oppido, Waleed Kian, J. R. Kumar, Antonios Polyzois, Saverio Bellomo, Zeru Jin, Walid Shalata, Keren Rouvinov, Lior Nesher, Alexander Yakobson	2021	1
14	Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers Science Advances ·Noam Shental, 憲雄赤坂, 晴津島, Malia Grosskreutz, 亜紀半田, Aner Ottolenghi, Yariv Greenshpan, Toyoki Takemom, Avishay Edri, Roni Gillis, SM Mukoya-Wangia, Fengmei Tao, Hong Tae Lim, Lilach M. Friedman, Lior Nesher, Yonat Shemer‐Avni, Angel Porgador, Tomer Hertz	2020	96
15	Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients Journal of Molecular Diagnostics ·Loralie J. Langman, Lior Nesher, Dimpy P. Shah, Jacques Azzi, Elizabeth J. Shpall, Katy Rezvani, John L. Black, Roy F. Chemaly	2016	3
16	Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patients Diagnostic Microbiology and Infectious Disease ·Kenneth V. I. Rolston, Claus Grewenig, Lior Nesher, Jordan R. Smith, Michael J. Rybak, Randall A. Prince	2016	8
17	Influenza Vaccination in Patients With Cancer: Factors Associated With Vaccination Practices for Patients and Their Household Members Infection Control and Hospital Epidemiology ·Ella Ariza‐Heredia, Jacques Azzi, Dimpy P. Shah, Lior Nesher, Shashank S. Ghantoji, 飯田則利, C. Mabbet, Roy F. Chemaly	2015	8
18	The current spectrum of infection in cancer patients with chemotherapy related neutropenia Infection ·Lior Nesher, Kenneth V. I. Rolston	2013	143
19	Neutropenic Enterocolitis, a Growing Concern in the Era of Widespread Use of Aggressive Chemotherapy Clinical Infectious Diseases ·Lior Nesher, K. V. I. Rolston	2012	107
20	Left spontaneous pneumothorax presenting with ST-segment elevations: A case report and review of the literature Heart & Lung ·Arthur Shiyovich, Dino A. Ruggiero, Lior Nesher	2011	21

About Lior Nesher

Lior Nesher is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Microbiology and Infectious Diseases, having authored 75 papers that have together received 1.5k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (14 papers), Antibiotic Resistance in Bacteria (12 papers), Neutropenia and Cancer Infections (9 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotic Use and Resistance (7 papers), Antifungal resistance and susceptibility (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Urinary Tract Infections Management (5 papers). The work is most often cited by research in Molecular Medicine (189 citations), Applied Microbiology and Biotechnology (65 citations), Infectious Diseases (503 citations), Clinical Biochemistry (141 citations) and Epidemiology (577 citations). Lior Nesher has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Kenneth V. I. Rolston, Roy F. Chemaly, Ella Ariza‐Heredia, K. V. I. Rolston, Carmi Bartal, Dimpy P. Shah, Arthur Shiyovich, Jeffrey Tarrand, ‪Yasmin Maor‬‏ and Galia Rahav. Their work appears in journals such as Infectious Diseases and Therapy, Infection, Infection Control and Hospital Epidemiology, Journal of Clinical Medicine and The Journal of Antibiotics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact